Page 1 of Clinical Trials for Myeloma, 1467 Total Matches
- 1RecruitingLast Updated: January 27, 2012Condition(s): Multiple Myeloma
- 2Active, not recruitingLast Updated: December 29, 2011Condition(s): Multiple Myeloma
- 3Not yet recruitingLast Updated: January 31, 2012Condition(s): Multiple Myeloma
- 4RecruitingLast Updated: December 21, 2011Condition(s): Multiple Myeloma
- 5RecruitingLast Updated: January 30, 2012Condition(s): Cancer; Myeloma; Multiple Myeloma
- 6RecruitingLast Updated: December 21, 2011Condition(s): Multiple Myeloma
- 7SuspendedLast Updated: November 1, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 8RecruitingLast Updated: January 26, 2012Condition(s): Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasma Cell Neoplasm
- 9RecruitingLast Updated: August 5, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
- 10Not yet recruitingAllogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionLast Updated: May 5, 2011Condition(s): Multiple Myeloma
- 11RecruitingLast Updated: August 4, 2011Condition(s): Multiple Myeloma
- 12Active, not recruitingLast Updated: April 29, 2009Condition(s): Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- 13RecruitingLast Updated: December 5, 2011Condition(s): Multiple Myeloma
- 14CompletedLast Updated: December 26, 2008Condition(s): Multiple Myeloma
- 15Not yet recruitingLast Updated: May 9, 2009Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 16Active, not recruitingLast Updated: August 17, 2011Condition(s): Multiple Myeloma
- 17RecruitingLast Updated: January 23, 2012Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 18CompletedLast Updated: September 21, 2007Condition(s): Graft vs Host Disease; Multiple Myeloma
- 19RecruitingLast Updated: February 3, 2012Condition(s): Multiple Myeloma
- 20CompletedLast Updated: June 4, 2011Condition(s): Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Myeloma
